Beta-mercaptolactate cysteine disulfiduria

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1035OMIM:249650E72.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Beta-mercaptolactate cysteine disulfiduria is an extremely rare metabolic condition in which the body has trouble breaking down certain sulfur-containing compounds. People with this condition excrete unusually high amounts of a substance called beta-mercaptolactate-cysteine disulfide in their urine. This happens because of a deficiency in an enzyme called mercaptopyruvate sulfurtransferase, which normally helps process sulfur-containing amino acids in the body. The condition was first described in the medical literature in the 1960s and 1970s. In some reported cases, individuals with this biochemical finding have had intellectual disability or other developmental concerns, but it remains unclear whether the enzyme deficiency directly causes these symptoms or whether they are coincidental findings. Some individuals with the same urine abnormality have been reported to be completely healthy, which makes the clinical significance of this condition uncertain. Because so few cases have been described in the medical literature, there is no established treatment specifically for this condition. Management, when needed, focuses on supportive care and addressing any developmental or neurological symptoms that may be present. Genetic counseling is recommended for affected families to understand the inheritance pattern and recurrence risk.

Also known as:

Key symptoms:

Unusual sulfur-containing compounds in the urineIntellectual disability (in some reported cases)Developmental delays (in some reported cases)Behavioral difficulties (reported in some individuals)Some individuals may have no symptoms at all

Clinical phenotype terms (24)— hover any for plain English
Hypoplasia of the ear cartilageHP:0100720
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Beta-mercaptolactate cysteine disulfiduria.

View clinical trials →

No actively recruiting trials found for Beta-mercaptolactate cysteine disulfiduria at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Beta-mercaptolactate cysteine disulfiduria community →

No specialists are currently listed for Beta-mercaptolactate cysteine disulfiduria.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Beta-mercaptolactate cysteine disulfiduria.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Beta-mercaptolactate cysteine disulfiduriaForum →

No community posts yet. Be the first to share your experience with Beta-mercaptolactate cysteine disulfiduria.

Start the conversation →

Latest news about Beta-mercaptolactate cysteine disulfiduria

No recent news articles for Beta-mercaptolactate cysteine disulfiduria.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Does my child's enzyme deficiency actually explain their symptoms, or could there be another cause?,Should we pursue genetic testing of the MPST gene to confirm the diagnosis?,Are there any dietary changes that might help manage this condition?,How often should we have follow-up metabolic testing?,What developmental support services would you recommend?,Is there a risk that other family members could be affected?,Are there any research studies or registries we should consider joining?

Common questions about Beta-mercaptolactate cysteine disulfiduria

What is Beta-mercaptolactate cysteine disulfiduria?

Beta-mercaptolactate cysteine disulfiduria is an extremely rare metabolic condition in which the body has trouble breaking down certain sulfur-containing compounds. People with this condition excrete unusually high amounts of a substance called beta-mercaptolactate-cysteine disulfide in their urine. This happens because of a deficiency in an enzyme called mercaptopyruvate sulfurtransferase, which normally helps process sulfur-containing amino acids in the body. The condition was first described in the medical literature in the 1960s and 1970s. In some reported cases, individuals with this bio

How is Beta-mercaptolactate cysteine disulfiduria inherited?

Beta-mercaptolactate cysteine disulfiduria follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.